Sigal Russo, CFO

Sigal Russo is a seasoned professional financial leader, bringing over 16 years of experience in key managerial positions in global, public Biotech and Pharmaceutical companies as well as in early-stage start-up companies, having previously worked for Mobilicom Ltd (ASX: MOB), OWC Pharmaceutical Research Corp. (OTCQB: OWCP) and Rosetta Genomics (NASDAQ: ROSG). Ms. Russo was also an audit manager at Ernst & Young in Israel, specializing in audits of companies from various sectors,  from 2004 to 2008. Ms. Russo holds a BA in Economics and Accounting, from the Ruppin Academic College.